ARMP
Armata Pharmaceuticals Inc
AMEX: ARMP · HEALTHCARE · BIOTECHNOLOGY
$3.29
+0.00% today
Updated 2026-10-29
Market cap
$114.15M
P/E ratio
—
P/S ratio
20.59x
EPS (TTM)
$-4.82
Dividend yield
—
52W range
$3 – $16
Volume
0.2M
Armata Pharmaceuticals Inc (ARMP) Insider transactions
Net insider activity
Net buying (44,911,549 shares)
Buy transactions
94
Sell transactions
6
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-24 | GILMER, DANIEL B. | Director | Buy | 51,280 | — | — |
| 2026-03-14 | KYME, PIERRE | Chief Business Officer | Sale | 1,030 | $10.54 | $10856.20 |
| 2026-03-14 | BIRX, DEBORAH | Director, Chief Executive Officer | Sale | 4,919 | $10.54 | $51846.26 |
| 2026-03-09 | SCHLESINGER, SARAH J. | Director | Buy | 25,640 | — | — |
| 2026-03-09 | PETERSON, TODD C. | Director | Buy | 25,640 | — | — |
| 2026-03-09 | PATTI, JOSEPH M | Director | Buy | 25,640 | — | — |
| 2026-03-09 | ODYSSEAS, KOSTAS D | Director | Buy | 25,640 | — | — |
| 2026-03-09 | KYME, PIERRE | Chief Business Officer | Buy | 183,142 | — | — |
| 2026-03-09 | KRAMER, ROBIN | Director | Buy | 25,640 | — | — |
| 2026-03-09 | HOUSE, DAVID DUANE | SVP, Finance, and PFO | Buy | 109,885 | — | — |
| 2026-03-09 | HAIMOVITZ, JULES | Director | Buy | 25,640 | — | — |
| 2026-03-09 | BIRX, DEBORAH | Director, Chief Executive Officer | Buy | 421,226 | — | — |
| 2025-07-10 | BIRX, DEBORAH | Director, Chief Executive Officer | Sale | 13,637 | $2.27 | $30955.99 |
| 2025-03-14 | KYME, PIERRE | Chief Business Officer | Sale | 1,027 | $1.95 | $2002.65 |
| 2025-03-14 | BIRX, DEBORAH | Director, Chief Executive Officer | Sale | 6,061 | $1.95 | $11818.95 |
| 2025-02-05 | SCHLESINGER, SARAH J. | Director | Buy | 54,343 | — | — |
| 2025-02-05 | PETERSON, TODD C. | Director | Buy | 54,343 | — | — |
| 2025-02-05 | PATTI, JOSEPH M | Director | Buy | 54,343 | — | — |
| 2025-02-05 | ODYSSEAS, KOSTAS D | Director | Buy | 54,343 | — | — |
| 2025-02-05 | KYME, PIERRE | Chief Business Officer | Buy | 100,000 | — | — |
| 2025-02-05 | KRAMER, ROBIN | Director | Buy | 54,343 | — | — |
| 2025-02-05 | HOUSE, DAVID DUANE | SVP, Finance, and PFO | Buy | 25,000 | — | — |
| 2025-02-05 | HAIMOVITZ, JULES | Director | Buy | 54,343 | — | — |
| 2025-02-05 | BIRX, DEBORAH | Director, Chief Executive Officer | Buy | 240,000 | — | — |
| 2024-10-02 | HOUSE, DAVID DUANE | SVP, Finance, and PFO | Buy | 75,000 | — | — |
| 2024-07-10 | BIRX, DEBORAH | Director, Chief Executive Officer | Sale | 22,925 | $2.68 | $61439.00 |
| 2024-03-14 | SCHLESINGER, SARAH J. | Director | Buy | 54,343 | — | — |
| 2024-03-14 | SCHLESINGER, SARAH J. | Director | Buy | 39,666 | — | — |
| 2024-03-14 | RYCHLIK, RICHARD | Corporate Controller and PFO | Buy | 40,000 | — | — |
| 2024-03-14 | RYCHLIK, RICHARD | Corporate Controller and PFO | Buy | 10,000 | — | — |
| 2024-03-14 | PETERSON, TODD C. | Director | Buy | 54,343 | — | — |
| 2024-03-14 | PETERSON, TODD C. | Director | Buy | 39,666 | — | — |
| 2024-03-14 | PATTI, JOSEPH M | Director | Buy | 54,343 | — | — |
| 2024-03-14 | PATTI, JOSEPH M | Director | Buy | 39,666 | — | — |
| 2024-03-14 | ODYSSEAS, KOSTAS D | Director | Buy | 54,343 | — | — |
| 2024-03-14 | ODYSSEAS, KOSTAS D | Director | Buy | 39,666 | — | — |
| 2024-03-14 | KRAMER, ROBIN | Director | Buy | 54,343 | — | — |
| 2024-03-14 | KRAMER, ROBIN | Director | Buy | 39,666 | — | — |
| 2024-03-14 | HAIMOVITZ, JULES | Director | Buy | 54,343 | — | — |
| 2024-03-14 | HAIMOVITZ, JULES | Director | Buy | 39,666 | — | — |
| 2024-03-14 | BIRX, DEBORAH | Director, Chief Executive Officer | Buy | 240,000 | — | — |
| 2024-03-14 | BIRX, DEBORAH | Director, Chief Executive Officer | Buy | 60,000 | — | — |
| 2023-12-21 | SCHLESINGER, SARAH J. | Director | Buy | 10,461 | — | — |
| 2023-12-21 | RYCHLIK, RICHARD | Corporate Controller and PFO | Buy | 50,000 | — | — |
| 2023-12-21 | PETERSON, TODD C. | Director | Buy | 10,461 | — | — |
| 2023-12-21 | PATTI, JOSEPH M | Director | Buy | 10,461 | — | — |
| 2023-12-21 | ODYSSEAS, KOSTAS D | Director | Buy | 10,461 | — | — |
| 2023-12-21 | KRAMER, ROBIN | Director | Buy | 10,461 | — | — |
| 2023-12-21 | HAIMOVITZ, JULES | Director | Buy | 10,461 | — | — |
| 2023-12-21 | BIRX, DEBORAH | Director, Chief Executive Officer | Buy | 200,000 | — | — |
| 2023-12-21 | BIRX, DEBORAH | Director, Chief Executive Officer | Buy | 200,000 | — | — |
| 2023-01-10 | INNOVIVA,, INC. | Director, 10% Owner | Buy | — | $30,000,000.00 | — |
| 2022-04-13 | VARNUM, BRIAN | President and CEO | Buy | 240,000 | — | — |
| 2022-04-13 | SCHLESINGER, SARAH J. | Director | Buy | 33,000 | — | — |
| 2022-04-13 | PETERSON, TODD C. | Director | Buy | 33,000 | — | — |
| 2022-04-13 | PATTI, JOSEPH M | Director | Buy | 33,000 | — | — |
| 2022-04-13 | PATRICK, TODD | Director | Buy | 33,000 | — | — |
| 2022-04-13 | ODYSSEAS, KOSTAS D | Director | Buy | 33,000 | — | — |
| 2022-04-13 | MORRIS, DUANE ALFRED | VP of Operations | Buy | 41,000 | — | — |
| 2022-04-13 | KRAMER, ROBIN | Director | Buy | 33,000 | — | — |
| 2022-04-13 | HAIMOVITZ, JULES | Director | Buy | 33,000 | — | — |
| 2022-03-31 | INNOVIVA,, INC. | Director, 10% Owner | Buy | — | $5.00 | — |
| 2022-03-31 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 5,385,208 | $5.00 | $26.93M |
| 2022-02-09 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 1,807,396 | $5.00 | $9.04M |
| 2022-02-09 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 3,614,792 | $5.00 | $18.07M |
| 2021-10-29 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 1,212,122 | $3.30 | $4.00M |
| 2021-08-02 | VARNUM, BRIAN | Director, CEO | Buy | 125,000 | — | — |
| 2021-06-07 | SCHLESINGER, SARAH J. | Director | Buy | 28,000 | — | — |
| 2021-06-07 | PETERSON, TODD C. | Director | Buy | 28,000 | — | — |
| 2021-06-07 | PATTI, JOSEPH M | Director | Buy | 28,000 | — | — |
| 2021-06-07 | ODYSSEAS, KOSTAS D | Director | Buy | 28,000 | — | — |
| 2021-06-07 | KRAMER, ROBIN | Director | Buy | 28,000 | — | — |
| 2021-04-01 | HAIMOVITZ, JULES | Director | Buy | 30,000 | — | — |
| 2021-03-25 | VARNUM, BRIAN | President and CDO | Buy | 112,000 | — | — |
| 2021-03-25 | PATRICK, TODD | Director, Chief Executive Officer | Buy | 112,000 | — | — |
| 2021-03-25 | MORRIS, DUANE ALFRED | VP of Operations | Buy | 28,000 | — | — |
| 2021-03-25 | MARTIN, STEVEN ROBERT | Chief Financial Officer | Buy | 56,000 | — | — |
| 2021-03-17 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 4,285,935 | $3.25 | $13.93M |
| 2021-03-17 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 4,285,935 | $3.25 | $13.93M |
| 2021-01-26 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 1,867,912 | $3.25 | $6.07M |
| 2021-01-26 | INNOVIVA,, INC. | Director, 10% Owner | Buy | 1,867,912 | $3.25 | $6.07M |
| 2020-12-08 | VARNUM, BRIAN | President and CDO | Buy | 23,000 | — | — |
| 2020-12-08 | SCHLESINGER, SARAH J. | Director | Buy | 23,000 | — | — |
| 2020-12-08 | PETERSON, TODD C. | Director | Buy | 23,000 | — | — |
| 2020-12-08 | PATTI, JOSEPH M | Director | Buy | 23,000 | — | — |
| 2020-12-08 | PATRICK, TODD | Director, Chief Executive Officer | Buy | 23,000 | — | — |
| 2020-12-08 | ODYSSEAS, KOSTAS D | Director | Buy | 23,000 | — | — |
| 2020-12-08 | MORRIS, DUANE ALFRED | VP of Operations | Buy | 23,000 | — | — |
| 2020-12-08 | MARTIN, STEVEN ROBERT | Chief Financial Officer | Buy | 23,000 | — | — |
| 2020-12-08 | KRAMER, ROBIN | Director | Buy | 30,000 | — | — |
| 2020-12-08 | BASTIANI, RICHARD | Director | Buy | 23,000 | — | — |
| 2020-03-27 | INNOVIVA,, INC. | 10% Owner | Buy | 7,717,661 | $2.87 | $22.15M |
| 2020-03-27 | INNOVIVA,, INC. | 10% Owner | Buy | 7,717,661 | $2.87 | $22.15M |
| 2020-02-12 | SCHLESINGER, SARAH J. | Director | Buy | 27,383 | — | — |
| 2020-02-12 | ODYSSEAS, KOSTAS D | Director | Buy | 27,383 | — | — |
| 2019-10-10 | PETERSON, TODD C. | Director | Buy | 27,383 | — | — |
| 2019-05-22 | VARNUM, BRIAN | President and CDO | Buy | 298,724 | — | — |
| 2019-05-22 | PERRY, MICHAEL S | Director | Buy | 27,383 | — | — |
| 2019-05-22 | PATTI, JOSEPH M | Director | Buy | 27,383 | — | — |
| 2019-05-22 | PATRICK, TODD | Director, Chief Executive Officer | Buy | 298,724 | — | — |
Frequently asked questions
Are ARMP insiders buying or selling?
Over the transactions on record, ARMP insiders have been net buyers, with about $168919.05 in stock sold across 6 sales, against 12 open-market purchases.
Does insider selling at ARMP mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which ARMP insiders are selling the most?
Recent selling is concentrated in a few names. BIRX, DEBORAH accounts for the largest share on record, with about $156060.20 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.